Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ENDRA Life Sciences Inc. - Common Stock
(NQ:
NDRA
)
4.760
-0.060 (-1.24%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about ENDRA Life Sciences Inc. - Common Stock
< Previous
1
2
3
4
Next >
$5 Stocks Gaining Attention for 2026: EKSO, NDRA, ONTF, FLYE, RDZN See Why Inside
Today 13:40 EST
Via
AB Newswire
ENDRA Life Sciences (NASDAQ: NDRA) Advances Health Tech (Alongside KYTX, RADX, GLSI IMNM) With a Next-Generation Treasury Strategy
December 15, 2025
Via
AB Newswire
ENDRA Life Sciences (NASDAQ: NDRA) Advances TAEUS® Liver Imaging, Strengthens Capital Efficiency; WVE, TWG, BDRX, FULC Also Active
December 09, 2025
Via
AB Newswire
Polyrizon (NASDAQ: PLRZ) Soars as Superior Mucoadhesion Naloxone Hydrogel Signals Stronger Real-World Opioid Overdose Reversal Potential
December 04, 2025
Via
AB Newswire
Topics
Artificial Intelligence
Death
ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use
December 04, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
ENDRA Life Sciences (NASDAQ: NDRA) Advances Treasury Flywheel and TAEUS® Liver Imaging Platform
December 02, 2025
Via
AB Newswire
Datavault AI (NASDAQ: DVLT) Licenses Healthcare IP to Wellgistics Health (NASDAQ: WGRX); Bonus Stocks in the News This Week TOON, NDRA, PRSO, RDZN more inside
November 26, 2025
Via
AB Newswire
Topics
Artificial Intelligence
Economy
Intellectual Property
ENDRA Life Sciences (NASDAQ: NDRA) Advances “Yield-to-Innovation” Strategy to Accelerate Breakthrough Liver Imaging Technology
November 24, 2025
Via
AB Newswire
ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker
November 20, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
The New Era of Treasury Strategy: ENDRA Life Sciences (NASDAQ: NDRA) Impacting Healthcare
November 18, 2025
Via
AB Newswire
ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results
November 17, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
ENDRA Life Sciences Inc. (NASDAQ: NDRA) Digital Asset Tokenization to Drive Long-Term Shareholder Value
November 14, 2025
Via
AB Newswire
ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA
November 13, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
TOMI Environmental (NASDAQ: TOMZ) | Norovirus Strain Shift Exposes Urgent Need for Next-Generation Disinfection
November 12, 2025
Via
AB Newswire
Topics
Artificial Intelligence
ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings
October 23, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca
October 13, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results
August 14, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
MAG 7 Undercard: $5 Stocks to Watch – NDRA, BSLK, WOLF, OCC, SNYR Poised for Action More Inside
July 08, 2025
Via
AB Newswire
ENDRA’s Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard
June 16, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results
May 15, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies
March 31, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update
March 31, 2025
From
ENDRA Life Sciences Inc.
Via
Business Wire
ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
November 22, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update
November 15, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
Study Highlighting ENDRA Life Sciences’ TAEUS Technology in Patients with High BMI to be Presented at AASLD’s The Liver Meeting® 2024
November 12, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent
November 06, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany
October 22, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements
August 28, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update
August 22, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
ENDRA Life Sciences Announces Reverse Stock Split
August 16, 2024
From
ENDRA Life Sciences Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
